Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 385.1M
Gross Profit 230.6M 59.88%
Operating Income -1.7M -0.45%
Net Income -12.1M -3.13%
EPS (Diluted) -$0.08

Balance Sheet Metrics

Total Assets 1.6B
Total Liabilities 516.4M
Shareholders Equity 1.1B
Debt to Equity 0.49

Cash Flow Metrics

Operating Cash Flow 86.6M
Free Cash Flow 59.4M

Revenue & Profitability Trend

Certara Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue385.1M354.3M335.6M286.1M243.5M
Cost of Goods Sold154.5M141.0M132.6M111.6M100.8M
Gross Profit230.6M213.3M203.1M174.5M142.8M
Operating Expenses178.8M161.6M127.4M120.1M127.3M
Operating Income-1.7M6.2M32.5M13.6M-24.4M
Pre-tax Income-17.2M-55.1M18.8M-3.4M-50.2M
Income Tax-5.1M214.0K4.0M9.9M-784.0K
Net Income-12.1M-55.4M14.7M-13.3M-49.4M
EPS (Diluted)-$0.08-$0.35$0.09-$0.09-$0.37

Income Statement Trend

Certara Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets310.9M340.2M342.3M274.7M346.6M
Non-Current Assets1.3B1.2B1.2B1.2B922.8M
Total Assets1.6B1.6B1.6B1.5B1.3B
Liabilities
Current Liabilities146.1M130.0M103.2M92.2M75.3M
Non-Current Liabilities370.4M386.3M390.1M377.7M371.9M
Total Liabilities516.4M516.3M493.3M469.9M447.3M
Equity
Total Shareholders Equity1.1B1.0B1.1B1.0B822.1M

Balance Sheet Composition

Certara Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income-12.1M-55.4M14.7M-13.3M-49.4M
Operating Cash Flow86.6M39.9M85.9M56.8M53.1M
Investing Activities
Capital Expenditures-----
Investing Cash Flow-91.3M-64.2M-15.3M-261.0M-675.0K
Financing Activities
Dividends Paid-----
Financing Cash Flow-21.0M-9.4M-7.4M123.4M188.3M
Free Cash Flow59.4M67.4M80.0M51.5M36.9M

Cash Flow Trend

Certara Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 104.00
Forward P/E 20.92
Price to Book 1.56
Price to Sales 4.33
PEG Ratio 20.92

Profitability Ratios

Profit Margin -0.67%
Operating Margin 7.19%
Return on Equity -0.25%
Return on Assets 1.12%

Financial Health

Current Ratio 2.78
Debt to Equity 28.51
Beta 1.45

Per Share Data

EPS (TTM) -$0.02
Book Value per Share $6.72
Revenue per Share $2.45

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
cert1.7B104.001.56-0.25%-0.67%28.51
Veeva Systems 46.0B59.927.3914.06%27.34%1.24
Ge Healthcare 32.6B14.953.5526.44%11.03%97.52
Premier 1.9B21.461.186.85%4.96%19.35
Schrodinger 1.5B44.394.05-43.33%-83.39%31.15
Omnicell 1.3B61.671.061.73%1.87%30.69

Financial data is updated regularly. All figures are in the company's reporting currency.